Business Emerald Health posts 32% sales drop, exits cannabis sector After too-bleak an outlook in legal weed, the firm says it can better secure shareholder value via pharmaceutical development Nick LabaNovember 30, 2021
Business Numinus develops in-house tests to detect compounds in psychedelic mushrooms The methods will be available as part of third-party client services Nick LabaNovember 29, 2021
Business Flowr Corp posts $9.2M loss in Q3 The firm says opportunities lie in new genetics and its EU GMP-certified operations in Portugal Nick LabaNovember 29, 2021
Business Delta, BC approves first pot shop after months-long process Another 7 applications in queue expected to move faster with support, councillor says Nick LabaNovember 26, 2021
Business Greenway makes adjusted EBITDA profit in first reported quarter Early feedback on the firm's cannabis products has been strong Nick LabaNovember 26, 2021
Business Cannabis NL reports steady profits, improved distribution In October, the province started fulfillment and delivery from its distribution centre in St. John's Nick LabaNovember 24, 2021
Business Losses mount for Planet 13 in Q3 Company executives say the quarter was important for securing future growth Nick LabaNovember 24, 2021
Business Organigram shares rise on 22% revenue boost The firm's new CEO looks to be off to a strong start Nick LabaNovember 23, 2021
Business Cronos continues to tumble after receiving Nasdaq delinquency letter The letter has no current impact on its listing, company says Nick LabaNovember 23, 2021
Business High Tide expands US presence with Colorado CBD acquisition deal The firm is buying 80% of NuLeaf for US$31M Nick LabaNovember 22, 2021